Benchmarking improves quality in cystic fibrosis care: A pilot project involving 12 centres

International Journal for Quality in Health Care

Volumn 23, Issue 3, 2011, Pages 349-356

  Stern, Martin ^a   Niemann, Nadja ^b   Wiedemann, Bärbel ^c   Wenzlaff, Paul ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Physicians' Chamber of Lower Saxony   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Benchmarking; Centre care; Cystic fibrosis; Epidemiology; Quality improvement

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; CYSTIC FIBROSIS; GERMANY; HEALTH CARE QUALITY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; NUTRITIONAL COUNSELING; PATIENT CARE; PRIORITY JOURNAL; QUALITY CONTROL; STANDARD;

ADOLESCENT; ADULT; BENCHMARKING; CHILD; CYSTIC FIBROSIS; DELIVERY OF HEALTH CARE; GERMANY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79956146266     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzr017     Document Type: Article

References (31)

1. Gawande A. The bell curve. Minn Med 2005;88:22-5; 58-59.
2. Corey M, McLaughlin FJ, Williams M et al. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-91.
3. Frederiksen B, Lanng S, Koch C et al. Improved survival in the Danish centre treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996;21:153-8.
4. Koch C, McKenzie SG, Kaplowitz H et al. International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF). Pediatr Pulmonol 1997;24:147-54.
5. Mahadeva R, Webb K, Westerbeek RC et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998;316:1771-5.
6. Konstan MW, Butler SM, Schidlow DV et al. For the investigators and coordinators of the Epidemiologic Study of Cystic Fibrosis. Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Pediatr Pulmonol 1999;28:242-7.
7. Konstan MW, Butler SM, Schidlow DV et al. For the investigators and coordinators of the Epidemiologic Study of Cystic Fibrosis. Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Pediatr Pulmonol 1999;28:248-54.
8. Schechter MA, Margolis P. Improving subspecialty healthcare: lessons from cystic fibrosis. J Pediatr 2005;147:295-301.
9. Acton JD, Kotagal U. Improvements in health care: how can we change the outcome? J Pediatr 2005;147:279-81.
10. Deming DE. Out of the Crisis. 2nd edn. Cambridge, MA, USA: Massachusetts Institute of Technology Press, 1986.
11. Stern M, Wiedemann B, Wenzlaff P on behalf of the German Cystic Fibrosis Quality Assessment group. From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995-2006. Eur Respir J 2008;31:29-35.
12. Stern M, Sens B, Wiedemann B et al. (eds). Qualitätssicherung Mukoviszidose 2006 - Ü berblick über den Gesundheitszustand der Patienten in Deutschland 2006. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft, 2008.
13. Stern M, Sens B, Niemann N et al. BMG-Modellprojekt 'Benchmarking bei der Versorgung von Mukoviszidose-Patienten/innen'. www.zq-aekn.de.
14. Reinken L, Van Oost G. Longitudinale Körperentwicklung gesunder Kinder von 0 bis 18 Jahren. Klin Pädiatr 1992;204:129-33.
15. Kromeyer-Hauschild K. Perzentile für den Body-Mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderh 2001;149:807-18.
16. Wiedemann B, Paul KD, Stern M et al., on behalf of the German CFQA Group. Evaluation of body mass index percentiles for assessment of malnutrition in children with cystic fibrosis. Eur J Clin Nutr 2007;61:759-68.
17. Zapletal A, Samanek M, Paul T. Lung Function in Children and Adolescents. Methods, Reference Values. Basel: Karger, 1987.
18. Quanjer PH. Standardized lung function testing. Report Working Party 'Standardization of lung function tests'. Bull Europ Physiopathol Respir 1983;19:S1-95.
19. Schmidt A, Wenninger K, Niemann N et al. Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R. Health Qual Life Outcomes 2009;7:97.
20. Boyle M. CF Benchmarking in USA. 21st European CF Conference, Prague, 15 June 2008 (oral presentation).
21. Quinton HB, O'Connor GT, for the Northern New England CV Cystic Fibrosis Consortium. Current issues in quality improvement in cystic fibrosis. Clin Chest Med 2007;28:459-72.
22. Padman R, McColley SA, Miller DP et al., for the investigators and coordinators of the epidemiologic study of cystic fibrosis. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics 2007;119:E531-7.
23. Thomas CL, O'Rourke PK, Wainwright CE. Clinical outcomes of Queensland children with cystic fibrosis: a comparison between tertiary centre and outreach services. Med J Aust 2008;188:135-9.
24. VanDevanter DR, Rasouliyan L, Murphy TM et al. Trends in the clinical characteristics of the US cystic fibrosis patient population from 1995 to 2005. Pediatr Pulmonol 2008;43:739-44.
25. www.zq-aekn.de/web_aekn/zqhome.nsf/ContentView/B9845430D423EAF2C12573EC0 02CBA78/$File/nl6_2008.pdf.
26. Kerem E, Conway S, Elborn S et al. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibr 2005;41:7-26.
27. Weiser G, Kerem E. Early intervention in CF: how to monitor the effect. Pediatr Pulmonol 2007;42:1002-7.
28. Goss CH, Burns JL. Exacerbations in cystic fibrosis 1: epidemiology and pathogenesis. Thorax 2007;62:360-7.
29. Flume PA, O'Sullivan BP, Robinson KA et al. Cystic Fibrosis Foundation, Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007;176:957-69.
30. Knudsen PK, Olesen HV, Hoiby N et al. Study Consortium (SCFSC). Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cystic Fibr 2009;8:135-42.
31. Kraynack NC, McBride JT. Improving care at cystic fibrosis centers through quality improvement. Semin Respir Crit Care Med 2009;30:547-58.